Editorials

The wolf of hypomethylating agent failure: what comes next?

Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Germany;German MDS Study Group (G-MDS);European Myelodysplastic Syndromes Cooperative Group (EMSCO group, www.emsco.eu)
Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Germany;German MDS Study Group (G-MDS);European Myelodysplastic Syndromes Cooperative Group (EMSCO group, www.emsco.eu)
Vol. 104 No. 8 (2019): August, 2019 https://doi.org/10.3324/haematol.2019.222794